
This Former Tech Executive Was Ready to Retire. Then an Obscure Molecule Gave Him a New Mission.
Published on June 12, 2025
Joel Kocher, CEO of humann, is betting on nitric oxide to change how people think about heart health.

Joel Kocher, CEO of humann, is betting on nitric oxide to change how people think about heart health.